Consonance Capital Management LP Care Dx, Inc. Transaction History

Consonance Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$30.88 - $37.94 $68.9 Million - $84.7 Million	-2,232,612 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$18.95 - $35.43 $8.11 Million - $15.2 Million	-428,104 Reduced 16.09%	2,232,612 $79.1 Million
Q1 2020 May 15, 2020	BUY	$13.94 - $28.25 $7.51 Million - $15.2 Million	538,740 Added 25.39%	2,660,716 $58.1 Million
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $26.9 Million - $39.7 Million	1,395,848 Added 192.23%	2,121,976 $45.8 Million
Q3 2019 Nov 14, 2019	BUY	$20.03 - $40.08 $14.5 Million - $29.1 Million	726,128 New	726,128 $16.4 Million

191

49.9M

60.8K

34.9K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.22B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.